UnitedHealth, Medicaid cuts, and a Congressman’s well-timed trade
UnitedHealth Group (UNH) has faced sustained pressure this year amid a fraud investigation, an earnings slump, and growing investor skepticism.
At the same time, political developments in Washington around Medicaid funding have added a quieter but notable dimension to concerns about the company’s outlook, intersecting with the actions of at least one lawmaker.
According to reporting by NBC News and statements from the Democratic Congressional Campaign Committee, Pennsylvania Republican Rep. Rob Bresnahan sold up to $130,000 worth of stock in May across four companies that together manage about half of all Medicaid enrollments nationwide.
UnitedHealth was among the companies whose shares were sold.
Roughly one week later, Bresnahan voted in favor of President Trump’s “One Big Beautiful Bill,” a sweeping budget package that included major reductions to Medicaid spending over time as part of a broader effort to offset tax cuts.
The timing has drawn scrutiny amid broader concerns about lawmakers trading stocks in industries directly affected by their legislative decisions. While the trades occurred in May, they became public months later, after NBC News obtained financial disclosure filings in November.
Uncertainty around Medicaid policy weighed on UnitedHealth shares over the summer. The stock sold off sharply before bottoming near $240 in early August, marking a decline of roughly 60% from its April highs.
Bresnahan told NBC News that he “never instructed my financial advisers on what to buy, sell, or hold.”
Still, the episode has raised renewed questions about whether lawmakers’ financial activities create conflicts of interest, particularly when policy decisions affect programs like Medicaid, which provide health coverage to millions of Americans.
The UnitedHealth-Medicaid link
UnitedHealth Group is a healthcare giant with a business broad enough to withstand many policy shifts, but major changes to Medicaid funding still carry meaningful implications for its bottom line.
Through its UnitedHealthcare insurance unit, the company operates Medicaid managed care plans in several states, providing coverage to low-income individuals and families. UnitedHealth is one of the largest private insurers participating in the Medicaid program.
Under these arrangements, UnitedHealth receives fixed payments from state and federal governments for each enrolled member, regardless of how much care that individual ultimately uses.
As a result, reductions in Medicaid funding or eligibility can pressure insurers through lower reimbursement rates, tighter spending caps, or declining enrollment.
Proposals like President Trump’s “One Big Beautiful Bill,” which calls for deep reductions in Medicaid spending over time, could therefore affect revenue and margins in UnitedHealth’s Medicaid business.
While ordinary Americans are unlikely to rally behind large corporations like UnitedHealth, public support for cutting Medicaid is limited.
A February KFF Health Tracking Poll found that just 17% of U.S. adults favor reducing federal spending on Medicaid. The overwhelming majority, 82%, said they want spending to either increase or remain at current levels.